Humoral immune response to Aggregatibacter actinomycetemcomitans leukotoxin

Journal of Periodontal Research

Volumn 46, Issue 2, 2011, Pages 170-175

  Brage, M ^a   Holmlund, A ^b   Johansson, A ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Aggregatibacter actinomycetemcomitans; Leukotoxin; Periodontitis; Systemic immunoreactivity

Indexed keywords

BACTERIAL TOXIN; BACTERIUM ANTIBODY; CYTOTOXIN; EXOTOXIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; LEUKOTOXIN;

ACUTE MONOCYTIC LEUKEMIA; AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ALVEOLAR BONE LOSS; ARTICLE; BLOOD; CASE CONTROL STUDY; CLASSIFICATION; COMPARATIVE STUDY; HEART INFARCTION; HUMAN; HUMORAL IMMUNITY; HYPERTENSION; IMMUNOLOGY; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; PERIODONTICS; PERIODONTITIS; TOOTH PLAQUE; TUMOR CELL LINE; WESTERN BLOTTING;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ALVEOLAR BONE LOSS; ANTIBODIES, BACTERIAL; BACTERIAL TOXINS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CYTOTOXINS; DENTAL PLAQUE INDEX; EXOTOXINS; HUMANS; HYPERTENSION; IMMUNITY, HUMORAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, MONOCYTIC, ACUTE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERIODONTAL INDEX; PERIODONTITIS;

EID: 79951922605     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2010.01325.x     Document Type: Article

References (36)

1. Pihlstrom BC, Michalowicz BS, Johnson DW. Periodontal diseases. Lancet 2005;366:1809-1820.
2. Darveau RP. Periodontitis: a polymicrobial disruption of host homeostasis. Nat Rev Microbiol 2010;8:481-490.
3. Nishihara T, Koseki T. Microbial etiology of periodontitis. Periodontol 2000 2004;36:14-26.
4. Ebersole JL. Humoral immune responses in gingival crevice fluid: local and systemic implications. Periodontol 2000 2003;31:135-166.
5. Kinane DF, Lappin DF. Immune processes in periodontal disease: a review. Ann Periodontol 2002;7:62-71.
6. Paster BJ, Olsen I, Aas JA, Dewhirst FE. The breadth of bacterial diversity in the human periodontal pocket and other oral sites. Periodontol 2000 2006;42:80-87.
7. Zambon JJ. Actinobacillus actinomycetemcomitans in human periodontal disease. J Clin Periodontol 1985;12:1-20.
8. Fine DH, Kaplan JB, Kachlany SC, Schreiner HC. How we got attached to Actinobacillus actinomycetemcomitans: a model for infectious diseases. Periodontol 2000 2006;42:114-157.
9. Van der Velden U, Abbas F, Armand S et al. Java project on periodontal diseases. The natural development of periodontitis: risk factors, risk predictors and risk determinants. J Clin Periodontol 2006;33: 540-548.
10. Åberg CH, Sjödin B, Lakio L, Pussinen P, Johansson A, Claesson R. Presence of Aggregatibacter actinomycetemcomitans in young individuals - a 16year clinical and microbiological follow-up study. J Clin Periodontol 2009;36:815-822.
11. Kelk P, Claesson R, Hänström L, Lerner UH, Kalfas S, Johansson A. Abundant secretion of bioactive IL-1β by human macrophages induced by Actinobacillus actinomycetemcomitans leukotoxin. Infect Immun 2005;73:453-458.
12. Kachlany SC. Aggregatibacter actinomycetemcomitans leukotoxin: from threat to therapy. J Dent Res 2010;89:561-570.
13. Haubek D, Ennibi OK, Poulsen K, Vaeth M, Poulsen S, Kilian M. Risk of aggressive periodontitis in adolescent carriers of the JP2 clone of Aggregatibacter (Actinobacillus) actinomycetemcomitans in Morocco: a prospective longitudinal cohort study. Lancet 2008;371:237-342.
14. Carlsson G, Wahlin Y-B, Johansson A et al. Periodontal disease in patients with severe congenital neutropenia of the original Kostmann family. J Periodontol 2006;77:744-751.
15. Kinane DF. Periodontitis modified by systemic factors. Ann Periodontol 1999;4:54-64.
16. Sjödin B, Arnrup K, Matsson L, Wranne L, Carlsson J, Hänström L. Periodontal and systemic findings in children with marginal bone loss in the primary dentition. J Clin Periodontol 1995;22: 214-224.
17. Källestål C, Matsson L, Persson S. Proximal attachment loss in Swedish adolescents. J Clin Periodontol 1991;18:760-765.
18. Rams TE, Listgarten MA, Slots J. Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis subgingival presence, species-specific serum immunoglobulin G antibody levels, and periodontitis disease recurrence. J Periodontal Res 2006;41:228-234.
19. Pussinen PJ, Paju S, Mäntylä P, Sorsa T. Serum microbial- and host-derived markers of periodontal diseases: a review. Curr Med Chem 2007;14:2402-2412.
20. Johansson A, Johansson I, Eriksson M, Åhrén A-M, Hallmans G, Stegmayr B. Systemic antibodies to the leukotoxin of the oral pathogen Actinobacillus actinomycetemcomitans correlate negatively with stroke in women. Cerebrovasc Dis 2005;20:226-232.
21. Johansson A, Buhlin K, Koski R, Gustafsson A. The immunoreactivity of systemic antibodies to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in adult periodontitis. Eur J Oral Sci 2005;113:197-202.
22. Tsai CC, McArthur WP, Baehni PC, Evian C, Genco RJ, Taichman NS. Serum neutralizing activity against Actinobacillus actinomycetemcomitans leukotoxin in juvenile periodontitis. J Clin Periodontol 1981;8:338-348.
23. McArthur WP, Tsai CC, Baehni PC, Genco RJ, Taichman NS. Leukotoxic effects of Actinobacillus actinomycetemcomitans. Modulation by serum components. J Periodontal Res 1981;16:159-170.
24. Califano JV, Pace BE, Gunsolley JC, Schenkein HA, Lally ET, Tew JG. Antibody reactive with Actinobacillus actinomycetemcomitans leukotoxin in early-onset periodontitis patients. Oral Microbiol Immunol 1997;12:20-26.
25. Holmlund A, Hedin M, Pussinen PJ, Lerner UH, Lind L. Porphyromonas gingivalis (Pg) a possible link between impaired oral health and acute myocardial infarction. Int J Cardiol 2009, doi: 10.1016/j.ijcard.2009.10.034.
26. Johansson A, Hänström L, Kalfas S. Inhibition of Actinobacillus actinomycetemcomitans leukotoxicity by bacterial proteases. Oral Microbiol Immunol 2000;15:218-225.
27. Ebersole JL, Sandoval MN, Steffen MJ, Cappelli D. Serum antibody in Actinobacillus actinomycetemcomitans-infected patients with periodontal disease. Infect Immun 1991;59:1795-1802.
28. Riep B, Edesi-Neuss L, Claessen F et al. Are putative periodontal pathogens reliable diagnostic markers? J Clin Microbiol 2009;47:1705-1711.
29. Vlachojannis C, Dye BA, Herrera-Abreu M et al. Determinants of IgG responses to periodontal bacteria in a nationally representative sample of US adults. J Clin Periodontol 2010;37:685-696.
30. Ebersole JL, Taubman MA, Smith DJ, Hammond BF, Frey DE. Human immune responses to oral microorganisms. II. Serum antibody responses to antigens from Actinobacillus actinomycetemcomitans and the correlation with localized juvenile periodontitis. J Clin Immunol 1983;3:321-331.
31. Engström PE, George M, Larsson P, Lally ET, Taichman NS, Norhagen G. Oral and systemic immunoglobulin G-subclass antibodies to Actinobacillus actinomycetemcomitans leukotoxin. Oral Microbiol Immunol 1999;14:104-108.
32. Podmore M, Ebersole JL, Kinane DF. Immunodominant antigens in periodontal disease: a real or illusive concept? Crit Rev Oral Biol Med 2001;12:179-185.
33. Johansson A, Claesson R, Hänström L, Sandström G, Kalfas S. Polymorphonuclear leukocyte degranulation induced by leukotoxin from Actinobacillus actinomycetemcomitans. J Periodontal Res 2000;35:85-92.
34. Claesson R, Johansson A, Belibasakis G, Hänström L, Kalfas S. Release and activation of matrix metalloproteinase 8 from human neutrophils triggered by the leukotoxin of Actinobacillus actinomycetemcomitans. J Periodontal Res 2002;37:353-359.
35. Hansson GK. Inflammatory mechanisms in atherosclerosis. J Thromb Haemost 2009;7(suppl 1):328-331.
36. Tonetti MS. Periodontitis and risk for atherosclerosis: an update on intervention trials. J Clin Periodontol 2009;36(suppl):15-19.